SCHEMBL7970126

SCHEMBL7970126

Cc1cccc(Cl)c1Nc1nc2cccc(OCCN3CCOCC3)c2n2cncc12

nearest known ligand 0.75

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.75
SRC P12931 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983711 0.89 LCK (0.94) LCKSRC
SCHEMBL4036754 0.86 LCK (0.72) LCKSRC
SCHEMBL7980325 0.86 LCK (1.00) LCK
SCHEMBL7970375 0.86 LCK (0.89) LCKSRC
SCHEMBL7987001 0.86 LCK (1.00) LCK
SCHEMBL7970210 0.85 LCK (0.76) LCK
SCHEMBL7983567 0.85 LCK (0.79) LCK
SCHEMBL7981589 0.84 LCK (0.80) LCKSRC
SCHEMBL7984301 0.84 LCK (0.75) LCK
SCHEMBL7979979 0.83 LCK (0.73) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed